Blog

Mar 06, 2025

Report: Influenza A and B clinically different, and type B patients less likely to receive antiviral | CIDRAP

SeventyFour / iStock Although they have similar 90-day death rates, influenza types A and B have unique clinical trajectories, and patients with type A are more likely to receive the antiviral drug

SeventyFour / iStock

Although they have similar 90-day death rates, influenza types A and B have unique clinical trajectories, and patients with type A are more likely to receive the antiviral drug oseltamivir (Tamiflu), French researchers report today in CMI Communications.

For the retrospective, multicenter study, the investigators evaluated adults who sought care at one of three tertiary-care hospitals and were diagnosed as having influenza A (234 patients) or B (113) from 2016 to 2018. They also characterized the clinical course by flu type and identified risk factors for poor outcomes across demographic factors, underlying medical conditions, and clinical parameters. The average patient age was 69 years, and 21% were vaccinated against flu.

"While both viruses share overlapping clinical presentations, influenza B circulates less widely due to its exclusive human reservoir and accounts for approximately 23% of annual cases in temperate regions," the researchers wrote. "Studies evaluating the differences in their epidemiology and patient outcomes remain limited, highlighting the need for further studies and targeted interventions."

Hospitalization rates were high in both groups, with 76.5% of influenza A patients and 70.8% of type B patients requiring admission. The average length of stay was 11 days for influenza A and 12 days for influenza B.

Influenza A and B patients had similar death rates by 90 days (13.4% vs 8.7%, respectively) and proportions of radiologic lung abnormalities (27.8% vs 24.8%), but those with type A were more likely to receive oseltamivir (43.5% vs 27.9% for type B).

"This may reflect clinicians' perception of greater severity in influenza A, as supported by previous studies, given its higher circulation," the researchers said of the oseltamivir prescribing disparities. "However, given the comparable ICU [intensive care unit] admission and mortality rates between influenza A and B, our findings suggest that oseltamivir could also benefit influenza B patients, particularly those with severe disease or risk factors for complications."

Older age (65 years and older) was the strongest risk factor for hospitalization (adjusted odds ratio [aOR], 4.78), while older age (aOR, 3.18), bilateral pulmonary involvement (aOR, 19.4), and receipt of osteltamivir (aOR, 2.43) were risk factors for ICU admission, with a trend toward coinfection with a bacterial pathogen requiring antibiotics (aOR, 2.56).

Despite the fact that influenza B has historically received less attention due to the dominance of influenza A pandemics, recent surveillance suggests that its disease burden may be greater than previously recognized, warranting increased focus in the post-COVID era.

In the short-term, influenza B patients had more favorable outcomes (aOR, 2.52), but chronic respiratory disease and higher scores on the Charlson Comorbidity Index lessened the odds of these outcomes (aOR, 0.34).

"While influenza B patients experienced better short-term (≤5 days) outcomes, overall they experienced more hospitalizations, ICU admissions, and mortality than expected," the study authors wrote. "Indeed, despite the fact that influenza B has historically received less attention due to the dominance of influenza A pandemics, recent surveillance suggests that its disease burden may be greater than previously recognized, warranting increased focus in the post-COVID era."

The findings highlight the need for earlier diagnostic tests and more equitable oseltamivir prescribing, the importance of managing coinfections, and broader vaccination policies tailored to both influenza types, they added.

New Mexico reported more cases in an adjacent county, with a few new confirmations from Texas in the community around Dallam and Hartley counties.

The study involved 68 US children who died from seasonal flu this season.

The county is in southwestern Indiana, on the border with Illinois and Kentucky, both of which are CWD-positive.

The Vaccines and Related Biological Products Advisory Committee was scheduled to meet March 13 to select virus strains for the 2025-26 flu vaccine.

In other measles news, Kentucky has reported a case in an adult who had recently traveled internationally.

The cats had no known exposure to infected poultry, livestock, raw milk, or raw meat, but they roamed freely outdoors, where they may have been exposed to wild birds or other animals.

Only 11% of survivors resumed full-time work by 6 months, while 12% went back to part-time work.

Texas health officials say there have been 20 hospitalizations in the outbreak, which began in late January.

The CDC notes that the poultry worker from Ohio had been hospitalized with respiratory and nonrespiratory symptoms.

Biosecurity support, streamlined financial relief for farmers, and vaccine and therapeutics investment are among the key steps.